Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial

IMPORTANCE: There is limited evidence regarding early treatment of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to mitigate symptom progression. OBJECTIVE: To examine whether high-dose zinc and/or high-dose ascorbic acid reduce the severity or duration of symptoms com...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Suma, Patel, Divyang, Bittel, Barbara, Wolski, Kathy, Wang, Qiuqing, Kumar, Anirudh, Il’Giovine, Zachary J., Mehra, Reena, McWilliams, Carla, Nissen, Steve E., Desai, Milind Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881357/
https://www.ncbi.nlm.nih.gov/pubmed/33576820
http://dx.doi.org/10.1001/jamanetworkopen.2021.0369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881357/
https://www.ncbi.nlm.nih.gov/pubmed/33576820
http://dx.doi.org/10.1001/jamanetworkopen.2021.0369

Ejemplares similares